Svetomir N Markovic

This inventor holds 66 USPTO granted patents and 29 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Cancer Treatments (CPC class A61K). Top assignees: Mayo Foundation for Medical Education and Research, Vavotar Life Sciences LLC. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Svetomir N Markovic. Retrieved from https://idiyas.com/inventor/svetomir-n-markovic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 66 (Patent Applications = 29)

% Patents Active = 98.5

CIPO Patents = 2 (Patent Applications = 13)

EPO Patents = 7 (Patent Applications = 27)

Average Co-Inventor Count = 2.0

ph-index = 27

Forward Citations = 1,161(Granted Patents)

Forward Citations (Not Self Cited) = 43(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Rohester, MN (US) (2019)
Rochester, MN (US) (2006 - 2024)

Company Filing History:

66 out of 1,808

Mayo Foundation for Medical Education and Research

patents

1 out of 1

Vavotar Life Sciences LLC

patent

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Cancer

Nanoparticle Complexes

Antibody Compositions

VEGF-Expressing Cancer

Triple-Negative Breast Cancer

Therapeutic Index

Hematologic Cancer

Paclitaxel

Albumin

Carrier-Binding Agents

Polypeptide-Antibody Complexes

Immunity Modeling

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12403119 - Treating lymphomas (2025-09-02),

2. 12364754 - Methods for treating VEGF-expressing cancer using preformed nanoparticle complexes comprising albumin-bound paclitaxel and bevacizumab (2025-07-22),

3. 12161718 - Unit dose of a composition for treating cancer (2024-12-10),

4. 11971412 - Polypeptide-antibody complexes and uses thereof (2024-04-30),

5. 11878061 - Methods for improving the therapeutic index for a chemotherapeutic drug (2024-01-23),

6. 11872205 - Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins (2024-01-16),

7. 11660339 - Methods of treating cancer using compositions of antibodies and carrier proteins with antibody pretreatment (2023-05-30),

8. 11655301 - Carrier-binding agent compositions and methods of making and using the same (2023-05-23),

9. 11648311 - Cancer treatments (2023-05-16),

10. 11590098 - Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins (2023-02-28),

11. 11571469 - Methods of treating cancer with interferon wherein the cancer cells are HLA negative or have reduced HLA expression (2023-02-07),

12. 11548946 - Carrier-PD-L1 binding agent compositions for treating cancers (2023-01-10),

13. 11531030 - Polypeptide-antibody complexes and uses thereof (2022-12-20),

14. 11439684 - Lymphocyte and monocyte populations in cancer patients and autologous stem cell preparations, and uses thereof (2022-09-13),

15. 11433023 - Albumin-PD-1 paclitaxel nanoparticle complex compositions and methods of making and using the same (2022-09-06),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will craft an article about inventor Svetomir N Markovic for you.

Title: Unveiling the Innovations of Inventor Svetomir N Markovic

Introduction:

In the realm of patents and groundbreaking discoveries, Svetomir N Markovic emerges as a prominent name in the innovation landscape. His prolific contributions have significantly impacted the fields of medical research and cancer treatment, with a remarkable track record of 63 patents to his name.

Latest Patents:

Among his latest patents, two notable innovations stand out:

1. Polypeptide-antibody complexes and uses thereof: Exploring the fusion of labeled polypeptides and antibodies, this patent showcases the utility of such complexes in research, diagnostics, and clinical applications.

2. Methods for improving the therapeutic index for a chemotherapeutic drug: Addressing the critical need for enhancing the effectiveness of chemotherapy while minimizing toxicity, this patent underscores Markovic's commitment to advancing cancer treatment strategies.

Career Highlights:

Svetomir N Markovic has been associated with esteemed institutions that have fostered his groundbreaking work. Notable among these are the Mayo Foundation for Medical Education and Research, where his innovative spirit found a nurturing environment, and Vavotar Life Sciences LLC, where his inventive prowess continued to thrive.

Collaborations:

In his journey of innovation, Markovic has collaborated with accomplished peers such as Wendy K Nevala and Gerald F Swiss. Together, they have synergized their expertise to drive forward cutting-edge research and translate ideas into tangible solutions.

Conclusion:

In conclusion, Svetomir N Markovic's contributions to the realms of medical research and cancer treatment are truly exemplary. His dedication to pushing the boundaries of innovation and his relentless pursuit of improved therapeutic solutions underscore his pivotal role in shaping the future of healthcare. With a rich tapestry of patents and a legacy of collaboration and excellence, Markovic stands as a beacon of inspiration for inventors and researchers alike.

Profile summary based on public USPTO records.